[1]房娟,任亮,张建鹏,等.疏风通窍汤联合富马酸卢帕他定治疗过敏性鼻炎临床研究[J].陕西中医,2019,(11):1590-1593.
 FANG Juan,REN Liang,ZHANG Jianpeng,et al.Shufeng Tongqiao decoction combined with rupatadine fumarate in the treatment of allergic rhinitis[J].,2019,(11):1590-1593.
点击复制

疏风通窍汤联合富马酸卢帕他定治疗过敏性鼻炎临床研究
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年11期
页码:
1590-1593
栏目:
临床研究
出版日期:
2019-11-05

文章信息/Info

Title:
Shufeng Tongqiao decoction combined with rupatadine fumarate in the treatment of allergic rhinitis
文章编号:
DOI:10.3969/j.issn.10007369.2019.11.028
作者:
房娟任亮张建鹏赵巍
陕西省商洛市中心医院耳鼻喉科(商洛 726000)
Author(s):
FANG JuanREN LiangZHANG Jianpenget al.
Department of Otolaryngology,Shangluo Central Hospital(Shangluo 726000)
关键词:
过敏性鼻炎疏风通窍汤富马酸卢帕他定症状积分体征积分血清IgE
Keywords:
Key words Allergic rhinitisShufeng Tongqiao decoctionRupatadine fumarateScores of clinical symptomsScores of physical signsSerum IgE
分类号:
R765.21
文献标志码:
A
摘要:
摘要目的:观察疏风通窍汤联合富马酸卢帕他定治疗过敏性鼻炎(AR)的疗效。 方法:将70例AR患者纳为研究对象,根据患者就医奇偶数次序,将其均分为联合组与对照组各35例,联合组采用疏风通窍汤配合富马酸卢帕他定治疗,对照组使用富马酸卢帕他定,药物治疗1个月后,比较两组治疗效果。 结果:两组治疗后,喷嚏、流涕、鼻塞、鼻痒等临床症状及体征积分均较治疗前显著下降(P<005),且联合组患者治疗后各临床症状及体征积分均显著低于对照组(P<005);治疗后,两组血清IgE、粉尘螨SIgE、屋尘SIgE、IL4及鼻腔分泌物EOS水平均较治疗前显著下降(P<005),且联合组治疗后以上物质水平均显著低于对照组(P<005);两组治疗后血清INFγ水平较治疗前显著上升(P<005),且联合组治疗后血清INFγ水平显著高于对照组(P<005);联合组治疗有效率高于对照组,但组间差异不显著(P>005);联合组治疗总有效率高于对照组,但组间差异不显著(P>005);两组不良反应无显著性差异(P>005)。 结论:疏风通窍汤联合富马酸卢帕他定能增强药物抗过敏功效,有效缓解AR临床症状与体征,且药物治疗安全性较高。
Abstract:
AbstractObjective:To observe the efficacy of Shufeng Tongqiao decoction combined with rupatadine fumarate in the treatment of allergic rhinitis (AR).Methods:Seventy patients with AR were included in the study.According to odevity of visiting sequence of patients,they were divided into combined group (Shufeng Tongqiao decoction with rupatadine fumarate,n=35) and control group (rupatadine fumarate,n=35).After 1 month of drug treatment,the therapeutic effects were compared between the two groups.Results:After treatment,the scores of clinical symptoms and physical signs of sneezing,runny nose,nasal congestion and nasal itching in the two groups were significantly lower than those before treatment (P<005),and the scores of clinical symptoms and physical signs in combined group after treatment were significantly lower than those in control group (P<005).After treatment,the levels of serum IgE,dermatophagoides farinae SIgE,house dust SIgE,IL4 and nasal secretion EOS in the two groups were significantly lower than those before treatment (P<005),and the levels of above indexes after treatment in combined group were significantly lower than those in control group (P<005).The serum INFγ level in the two groups after treatment was significantly higher than that before treatment (P<005),and the serum INFγ level in combined group after treatment was significantly higher than that in control group (P<005).The effective rate of treatment in combined group was higher than that in control group (P>005).The total effective rate of treatment in combined group was higher than that in control group (P>005).There were no significant differences in the adverse reactions between the two groups (P>005).Conclusion: Shufeng Tongqiao decoction combined with rupatadine fumarate can enhance the antiallergic effects of the drug,and effectively alleviate the clinical symptoms and physical signs of AR,with high safety of drug treatment.

参考文献/References:

[1]弓少康,高丹,李少滨,等.1197例过敏性鼻炎患者中医体质分析[J].中国中医急症,2018,27(12):21762178.
[2]中华耳鼻咽喉头颈外科杂志编委会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎诊断和治疗指南 [J].中华耳鼻咽喉头颈外科杂志,2009,44(12):977978.
[3]刘大新.中医耳鼻喉科常见病诊疗指南国家中医药管理局中医药标准化项目\[C\].中华中医药学会耳鼻喉科分会第十六次全国学术交流会论文集,2010:937.
[4]刘永平,陈蕴光,郑俊斌,等.变应性鼻炎鼻激发后鼻腔分泌物嗜酸性粒细胞增加与血清特异性IgE水平正相关[J].细胞与分子免疫学杂志,2017,33(1):8588.
[5]王玲,胡雅琳,杨蕊铭,等.过敏性鼻炎合并哮喘患者血液嗜酸性粒细胞富集群中IL18、IL18 BP及IL18 R的表达[J].郑州大学学报:医学版,2017,52(5):598602.
[6]朱正阳,戚凯明,宣丽华.冬病夏治不同穴位贴敷对过敏性鼻炎患者血清IgE的影响[J].中医杂志,2018,59(3):220223.
[7]臧艳艳,柴文戍,王君灵,等.过敏性鼻炎合并哮喘患者血液嗜酸性粒细胞群中P物质及其受体表达上调[J].西安交通大学学报:医学版,2018,39(2):250255.
[8]娄鸿飞,马思远,赵岩,等.京津冀地区自报过敏性鼻炎病人吸入过敏原检测临床相关性分析[J].首都医科大学学报,2017,38(5):665670.
[9]邢春华,蔡育兵,丁菲,等.富马酸卢帕他定片治疗慢性特发性荨麻疹的有效性及安全性[J].中国医院药学杂志,2017,37(13):12711274.
[10]侯贻魁,夏继宁,钟梅,等.卢帕他定和咪唑斯汀治疗慢性荨麻疹疗效观察[J].中华皮肤科杂志,2017,50(10):754755.
[11]谢成彬,唐凤翔,廖兵.富马酸卢帕他定治疗过敏性鼻炎的临床疗效观察[J].重庆医学,2018,47(23):30643067.
[12]曲中源,王爱平,曲汝鹏,等.孙海波基于伏邪致病理论治疗过敏性鼻炎经验[J].辽宁中医杂志,2018,45(12):4143.
[13]黄瑶,师大智,谭晓梅,等.麻黄附子细辛汤抗过敏性鼻炎有效组分的组方研究[J].中国药房,2017,28(19):4952.
[14]陈盼碧,宣锦,史林威,等.热敏灸对过敏性鼻炎大鼠血清IgE、IL4含量的影响[J].中国现代医学杂志,2017,27(4):1721.
[15]杨军,王敏,张罗.细胞因子和免疫球蛋白抗体在过敏性鼻炎小鼠早期无症状阶段和晚期有症状阶段表达的差异[J].首都医科大学学报,2018,39(1):6368.
[16]臧焕焕,胡珀,王灵甫,等.基于IL27探讨益气祛风、宣痹化饮方治疗过敏性鼻炎哮喘综合征的作用机制[J].中成药,2018,40(2):447452.
[17]黄攀峰,黄秋节.益气固表通窍法治疗过敏性鼻炎的疗效观察[J].中国中医急症,2017,26(5):869871.

相似文献/References:

[1]石德祥,张美丽△.鼻炎康片联合曲安奈德穴位注射治疗过敏性鼻炎疗效及对患者生活质量影响[J].陕西中医,2019,(10):1431.
[2]王智芳,黄建乐△.祛风宣痹方联合孟鲁司特钠治疗过敏性鼻炎哮喘综合征临床研究*[J].陕西中医,2020,(5):629.[doi:DOI:10.3969/j.issn.10007369.2020.05.021]
 WANG Zhifang,HUANG Jianle..Clinical effect of Qufeng Xuanbi decoction combined with montelukast sodium in the treatment of allergic rhinitis and asthma syndrome[J].,2020,(11):629.[doi:DOI:10.3969/j.issn.10007369.2020.05.021]
[3]刘顺利,梁萌萌,刘大英,等.黄芪多糖对过敏性鼻炎大鼠Treg/Th17细胞免疫平衡和炎症因子的影响[J].陕西中医,2023,(1):20.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.005]
 LIU Shunli,LIANG Mengmeng,LIU Daying,et al.Effects of astragalus polysaccharides on immune balance and inflammatory factors of Treg/Th17 cells in a rat of allergic rhinitis[J].,2023,(11):20.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.005]
[4]沈毅韵,朱一冰,张艳涛,等.肺脾肾湿论治小儿过敏性鼻炎作用机制研究进展[J].陕西中医,2023,(1):133.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.033]
 SHEN Yiyun,ZHU Yibing,ZHANG Yantao,et al.Research progress on the mechanism of treating allergic rhinitis in children with the theory of lung,spleen and kidney dampness[J].,2023,(11):133.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.033]
[5]冯逸杰,郭新荣,晁姣姣,等.郭新荣基于“疏通调补”学术思想针药结合治疗过敏性鼻炎经验[J].陕西中医,2024,(10):1399.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.023]

备注/Memo

备注/Memo:
*陕西省科学技术研究发展计划项目(S2017JL836512)
更新日期/Last Update: 2019-11-15